No patients in this cohort demonstrated an adverse reaction after ICG injection for SLN mapping. This study supports the reasonable safety of ICG in patients with contrast allergies, particularly when routine ERAS protocols containing dexamethasone are utilized.
Keyphrases
- sentinel lymph node
- endometrial cancer
- end stage renal disease
- high resolution
- magnetic resonance
- lymph node
- early stage
- fluorescence imaging
- newly diagnosed
- chronic kidney disease
- neoadjuvant chemotherapy
- ejection fraction
- prognostic factors
- low dose
- peritoneal dialysis
- high dose
- emergency department
- squamous cell carcinoma
- contrast enhanced
- radiation therapy
- patient reported outcomes
- rectal cancer
- drug induced